Skip to content

Combination supplement trial reports fewer respiratory infections in children with recurrent illness

The abstract evaluates a mixture of vitamins, minerals, herbal extracts and Lactobacillus rhamnosus CRL1505 in children with recurrent infections.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Children receiving the combination had fewer respiratory infection episodes on average than those given placebo during observation. The authors also report fewer illness and symptom days, and fewer days of fever-medicine or antibiotic use per episode. They describe the product as well tolerated, but the abstract does not identify which ingredients contributed to these differences.

Keep in mind

The abstract gives no initial randomized sample size, ingredient amounts or adverse-event counts. It also leaves the variability terms accompanying the infection averages undefined, limiting assessment of uncertainty and safety.

THE NUMBERS, WITH CONTEXT

What researchers found

2.41 vs. 4.13 episodes per child

Mean respiratory infection count

Combination supplement versus placebo over 4 months; the authors report a statistically significant difference.

Children (Basel), 2026 · Original source ↓

Who the findings concern

Children qualified because they had experienced repeated respiratory infections during the preceding year. That entry requirement defines whom the trial studied and limits what its results establish for children with a different infection history.

What the comparison can establish

The study compared the complete mixture with placebo. It cannot separate the contribution of Lactobacillus rhamnosus CRL1505 from those of the vitamins, minerals or herbal extracts, so its results do not establish effects of individual ingredients.

CHECK THE ORIGINAL

The original publication

Evaluation of the Effects of an Immune-Boosting Food Supplement on the Severity and Frequency of Pediatric Respiratory Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Calapai F, Ammendolia I, Mannucci C et al.
Children (Basel) · 2026

PubMed ID
41897140
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.